K. Kolandaivelu

发表

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

E. Edelman, V. L. Giddings, V. Kolachalama, 2011, Circulation.

Non-adherence to cardiovascular medications.

Deepak L. Bhatt, K. Kolandaivelu, P. O'Gara, 2014, European heart journal.

Microbial lysate upregulates host oxytocin

K. Kolandaivelu, E. Alm, S. Erdman, 2016, Brain, Behavior, and Immunity.

Predicting response to endovascular therapies: dissecting the roles of local lesion complexity, systemic comorbidity, and clinical uncertainty.

E. Edelman, K. Kolandaivelu, Benjamin Leiden, 2014, Journal of biomechanics.

The development of an in vitro model of coronary lesion thrombosis

K. Kolandaivelu, 2003 .

The development and application of an in vitro model of coronary lesion thrombosis

K. Kolandaivelu, 2005 .

Targeting STUB1–tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk

Mostafa E. Belghasem, E. Edelman, V. Kolachalama, 2017, Science Translational Medicine.

Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration.

E. Edelman, K. Kolandaivelu, M. Balcells, 2018, Biomacromolecules.

Targeting STUB 1-tissue factor axis normalizes the hyperthrombotic uremic phenotype without increasing the bleeding risk

Mostafa E. Belghasem, E. Edelman, V. Kolachalama, 2017 .

A miniature mechanical ventilator for newborn mice.

K. Kolandaivelu, C. Poon, 1998, Journal of applied physiology.

Evolution of functional antibodies following acute Epstein-Barr virus infection

K. Kolandaivelu, G. Alter, Matthew D. Slein, 2022, PLoS pathogens.

Vascular Response to Experimental Stent Malapposition and Under-Expansion

Caroline C. O'Brien, E. Edelman, V. Kolachalama, 2016, Annals of Biomedical Engineering.

Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis.

K. Kolandaivelu, N. Kleiman, 2015, Journal of the American College of Cardiology.

Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence

Deepak L. Bhatt, K. Kolandaivelu, 2010, Nature Reviews Cardiology.

Novel Antiplatelet Therapies

K. Kolandaivelu, D. Bhatt, 2019, Platelets.

Chapter 58 – Novel Antiplatelet Therapies

Deepak L. Bhatt, K. Kolandaivelu, 2013 .

Uremic Serum and Solutes Increase Post–Vascular Interventional Thrombotic Risk Through Altered Stability of Smooth Muscle Cell Tissue Factor

E. Edelman, K. Kolandaivelu, I. Bosch, 2012, Circulation.

Antiplatelet therapy in coronary heart disease prevention.

Deepak L. Bhatt, K. Kolandaivelu, 2011, Cardiology clinics.

Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis.

E. Edelman, K. Kolandaivelu, 2002, Journal of biomechanical engineering.

Environmental influences on endovascular stent platelet reactivity: an in vitro comparison of stainless steel and gold surfaces.

E. Edelman, K. Kolandaivelu, 2004, Journal of biomedical materials research. Part A.

Solvent-cast direct-writing as a fabrication strategy for radiopaque stents

K. Kolandaivelu, M. Ginebra, M. Pegueroles, 2021, Additive Manufacturing.

The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.

E. Edelman, K. Kolandaivelu, J. Weinberg, 2016, Journal of the American Society of Nephrology : JASN.

Extent of flow recirculation governs expression of atherosclerotic and thrombotic biomarkers in arterial bifurcations.

Elazer R Edelman, Vijaya B Kolachalama, Kumaran Kolandaivelu, 2014, Cardiovascular research.

A randomised trial of lung sealant versus medical therapy for advanced emphysema

G. Washko, M. Wahidi, G. Criner, 2015, European Respiratory Journal.

Enhancing physiologic simulations using supervised learning on coarse mesh solutions

Elazer R. Edelman, Vijaya B. Kolachalama, Caroline C. O'Brien, 2015, Journal of The Royal Society Interface.

Constraining OCT with Knowledge of Device Design Enables High Accuracy Hemodynamic Assessment of Endovascular Implants

Elazer R. Edelman, Vijaya B. Kolachalama, Caroline C. O'Brien, 2016, PloS one.

The Systems Biocompatibility of Coronary Stenting.

Kumaran Kolandaivelu, K. Kolandaivelu, Farhad Rikhtegar, 2016, Interventional cardiology clinics.

Ultra-hydrophilic stent platforms promote early vascular healing and minimise late tissue response: a potential alternative to second-generation drug-eluting stents.

Deepak L. Bhatt, A. Tzafriri, E. Edelman, 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Quantification of thrombus formation in malapposed coronary stents deployed in vitro through imaging analysis.

Elazer R Edelman, Caroline C. O'Brien, Kumaran Kolandaivelu, 2018, Journal of biomechanics.

Degree of bioresorbable vascular scaffold expansion modulates loss of essential function.

Jahid Ferdous, Vijaya B Kolachalama, Kumaran Kolandaivelu, 2015, Acta biomaterialia.

Non-adherence to cardiovascular medications.

Deepak L. Bhatt, K. Kolandaivelu, P. O'Gara, 2014, European heart journal.

Microbial lysate upregulates host oxytocin

K. Kolandaivelu, E. Alm, S. Erdman, 2016, Brain, Behavior, and Immunity.

Optimizing glutaraldehyde-fixed tissue heart valves with chondroitin sulfate hydrogel for endothelialization and shield against deterioration

E. Edelman, K. Kolandaivelu, M. Balcells, 2018 .